Loss of Cadherin-11 in pancreatic ductal adenocarcinoma alters tumor-immune microenvironment

CDH11 Biomedical and Clinical Sciences Oncology and Carcinogenesis Immunology MDSC T cells 610 PDAC Neoplasms. Tumors. Oncology. Including cancer and carcinogens Clinical sciences Oncology and carcinogenesis 3. Good health Pancreatic Cancer Orphan Drug Rare Diseases Oncology 2.1 Biological and endogenous factors IL33 Immunotherapy Aetiology CAF Digestive Diseases RC254-282 Cancer
DOI: 10.3389/fonc.2023.1286861 Publication Date: 2023-10-26T23:05:01Z
ABSTRACT
Pancreatic ductal adenocarcinoma (PDAC) is one of the top five deadliest forms cancer with very few treatment options. The 5-year survival rate for PDAC 10% following diagnosis. Cadherin 11 (Cdh11), a cell-to-cell adhesion molecule, has been suggested to promote tumor growth and immunosuppression in PDAC, Cdh11 inhibition significantly extended mice PDAC. However, mechanisms by which deficiency influences progression anti-tumor immune responses have yet be fully elucidated. To investigate -deficiency induced changes microenvironment (TME), we crossed p48-Cre; LSL-Kras G12D/+ ; LSL-Trp53 R172H/+ (KPC) +/- performed single-cell RNA sequencing (scRNA-seq) non-immune (CD45 - ) + compartment KPC tumor-bearing proficient ( KPC-Cdh11 +/+ deficient mice. Our analysis showed that expressed primarily cancer-associated fibroblasts (CAFs) at low levels epithelial cells undergoing epithelial-to-mesenchymal transition (EMT). altered molecular profile CAFs, leading decrease expression myofibroblast markers such as Acta2 Tagln cytokines Il6 , Il33 Midkine (Mdk) . We also observed significant presence monocytes/macrophages neutrophils tumors while proportion T was increased. Additionally, myeloid lineage from -deficient had reduced immunosuppressive previously shown play role suppression. In summary, our data suggests alters fibroblast microenvironments contributes reduction cytokines, an increase immunity enhanced survival.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (63)
CITATIONS (1)